Ultrasound

Ventripoint expands access to cardiac imaging platform
By AuntMinnie.com staff writers
The commercial push follows Ventripoint's July selection for the Intelligence Reconstruction of Echocardiography Study (AIRES).
August 12, 2026
Heart 1
Vexev raises $6M for vascular imaging platform
By AuntMinnie.com staff writers
VxWave combines robotics, AI, and ultrasound to automate vascular ultrasound acquisition, with dialysis vascular access as its initial application.
August 6, 2026
Cash
GE HealthCare launches Logiq e compact ultrasound system family
By AuntMinnie.com staff writers
The Logiq e X and Logiq e S systems are designed for point-of-care use across a variety of clinical settings.
August 4, 2026
Logiq e X
HistoSonics gets CE Mark for histotripsy system
By AuntMinnie.com staff writers
The system uses histotripsy, a noninvasive focused ultrasound technology that mechanically destroys liver tumors without surgery, needles, radiation, or heat.
July 13, 2026
Histosonics System (2) (1) (1)
Philips launches new ultrasound system
By AuntMinnie.com staff writers
The system features AI-powered workflows and is designed for high-volume clinical environments.
July 8, 2026
Alturion
Canon Medical, Fraiya partner for AI prenatal ultrasound in Europe
By AuntMinnieEurope.com staff writers
Imaging focuses on the mid-trimester anomaly scan.
June 26, 2026
Image2
BrightHeart receives CE mark for prenatal ultrasound AI platform
By AuntMinnieEurope.com staff writers
The CE mark follows an €11 million series A funding round.
June 24, 2026
Ai2
Canon unveils Aplio me X ultrasound system at Euroson 2026
By AuntMinnieEurope.com staff writers
Canon Medical Systems unveiled its Aplio me X diagnostic ultrasound system at Euroson 2026.
June 18, 2026
Aplio me X ultrasound system
E-Scopics wins FDA clearance for hepatoscope technology
By AuntMinnie.com staff writers
The technology demonstrated a 0.93 correlation coefficient with MRI-based proton density fat fraction.
June 17, 2026
Liver
Video: Dr. Alba Pugliesi on what keeps her dreams big
By Claudia Tschabuschnig
In a video interview, radiologist Dr. Rosa Alba Pugliesi shares how limits are only in your head.
June 16, 2026
Dr. Alba Pugliesi
U.K. ultrasound consortium releases manifesto
By AuntMinnieEurope.com staff writers
Document outlines actions to strengthen diagnostic ultrasound services.
June 16, 2026
Ukio Ultrasound Manifesto Launch
Image-guided focal laser ablation effective for prostate cancer
By Amerigo Allegretto
MRI-directed, ultrasound-guided TPLA may be a promising technique to treat prostate cancer while avoiding radical therapies.
June 3, 2026
Preablation, postablation, and recurrence multiparametric MRI scans depict a 63-year-old man treated with transperineal focal laser ablation (TPLA) for localized prostate cancer. Clinical parameters included an initial prostate-specific antigen (PSA) level of 7.2 ng/mL, a Prostate Imaging Reporting and Data System (PI-RADS) grade 4 lesion (red circles) in the right apical peripheral zone, and a maximum tumor length of 5 mm. MRI-guided targeted biopsy confirmed a Gleason score 3+4 prostate cancer tumor. (A) Pre-ablation axial T2-weighted MRI scan and apparent diffusion coefficient (ADC) image shows the apical PI-RADS 4 lesion (circles). (B) Six-month post-ablation axial T2-weighted MRI scan and ADC image show cystic necrosis (arrows). There was no evidence of recurrence; the PSA level was 1.5 ng/mL. (C) One-year after ablation, the patient’s PSA level had increased to 4.3 ng/mL. Axial T2-weighted MRI scan and the ADC image shows a recurrent lesion (blue circles) in the right apical peripheral zone adjacent to the ablation scar. Targeted biopsy confirmed Gleason score 3+4 prostate cancer, which was classified as in-field recurrence of clinically significant prostate cancer and subsequently re-treated with TPLA. In summary, serial multiplanar MRI demonstrates treatment response after TPLA with post-ablation necrosis, followed by MRI-detected IFR confirmed with biopsy at 12-month follow-up. Multiparametric MRI was performed with a 3.0-T MRI scanner (Skyra; Siemens Healthineers) using T2-weighted, diffusion-weighted, and ADC sequences, with gadobenate dimeglumine contrast material administration (Bracco Diagnostics).
Page 1 of 126
Next Page